Asthma "of horses and men"-How can equine heaves help us better understand human asthma immunopathology and its functional consequences?

Molecular Immunology

Volumn 66, Issue 1, 2015, Pages 97-105

  Bullone, Michela ^a   Lavoie, Jean Pierre ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Airway remodeling; Animal model; Asthma; Horse; Immunology; Inflammation

Indexed keywords

AGING; AIRWAY REMODELING; ALLERGIC REACTION; ASTHMA; BRONCHUS MUCOSA; EQUIDAE; HELMINTH; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOLOGY; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; REVIEW; ANIMAL; HORSE; HORSE DISEASE; IMMUNOLOGY; INFLAMMATION; LUNG; NEUTROPHIL CHEMOTAXIS; PATHOLOGY;

ANIMALS; ASTHMA; HORSE DISEASES; HORSES; HUMANS; INFLAMMATION; LUNG; NEUTROPHIL INFILTRATION; NEUTROPHILS;

EID: 84925505646     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2014.12.005     Document Type: Review

References (122)

1. Adams A.A., Breathnach C.C., Katepalli M.P., Kohler K., Horohov D.W. Advanced age in horses affects divisional history of T cells and inflammatory cytokine production. Mech. Ageing Dev. 2008, 129:656-664.
2. Ainsworth D.M., Grunig G., Matychak M.B., Young J., Wagner B., Erb H.N., Antczak D.F. Recurrent airway obstruction (RAO) in horses is characterized by IFN-gamma and IL-8 production in bronchoalveolar lavage cells. Vet. Immunol. Immunopatol. 2003, 96:83-91.
3. Ainsworth D.M., Wagner B., Franchini M., Grunig G., Erb H.N., Tan J.Y. Time-dependent alterations in gene expression of interleukin-8 in the bronchial epithelium of horses with recurrent airway obstruction. Am. J. Vet. Res. 2006, 67:669-677.
4. Barnes K.C., Grant A.V., Gao P. A review of the genetic epidemiology of resistance to parasitic disease and atopic asthma: common variants for common phenotypes?. Curr. Opin. Allergy Clin. Immunol. 2005, 5:379-385.
5. Beadle R.E., Horohov D.W., Gaunt S.D. Interleukin-4 and interferon-gamma gene expression in summer pasture-associated obstructive pulmonary disease affected horses. Equine Vet. J. 2002, 34:389-394.
6. Berndt A., Derksen F.J., Venta P.J., Ewart S., Yuzbasiyan-Gurkan V., Robinson N.E. Elevated amount of Toll-like receptor 4 mRNA in bronchial epithelial cells is associated with airway inflammation in horses with recurrent airway obstruction. Am. J. Physiol. Lung Cell. Mol. Physiol. 2007, 292:L936-L943.
7. Bhavsar P., Khorasani N., Hew M., Johnson M., Chung K.F. Effect of p38 MAPK inhibition on corticosteroid suppression of cytokine release in severe asthma. Eur. Respir. J. 2010, 35:750-756.
8. Boivin R., Vargas A., Lefebvre-Lavoie J., Lauzon A.M., Lavoie J.P. Inhaled corticosteroids modulate the (+)insert smooth muscle myosin heavy chain in the equine asthmatic airways. Thorax 2014, 69:1113-1119.
9. Bos I.S., Gosens R., Zuidhof A.B., Schaafsma D., Halayko A.J., Meurs H., Zaagsma J. Inhibition of allergen-induced airway remodelling by tiotropium and budesonide: a comparison. Eur. Respir. J. 2007, 30:653-661.
10. Brazil T.J., Dagleish M.P., McGorum B.C., Dixon P.M., Haslett C., Chilvers E.R. Kinetics of pulmonary neutrophil recruitment and clearance in a natural and spontaneously resolving model of airway inflammation. Clin. Exp. Allergy 2005, 35:854-865.
11. Brundler P., Frey C.F., Gottstein B., Nussbaumer P., Neuhaus S., Gerber V. Lower shedding of strongylid eggs by Warmblood horses with recurrent airway obstruction compared to unrelated healthy horses. Vet. J. 2011, 190:e12-e15.
12. Bullone M., Chevigny M., Allano M., Martin J.G., Lavoie J.P. Technical and physiological determinants of airway smooth muscle mass in endobronchial biopsy samples of asthmatic horses. J. Appl. Physiol. 2014, 117:806-815.
13. Bullone M., Godbout M., Martin G.J., Lavoie J.P. Endobronchial ultrasonography of isolated bronchi reveals increased airway smooth muscle mass in large airways of asthmatic horses. Am. J. Respir. Crit. Care Med. 2014, 189:A2382.
14. Busse P.J., Mathur S.K. Age-related changes in immune function: effect on airway inflammation. J. Allergy Clin. Immunol. 2010, 126:690-699. quiz 700-1.
15. Bureau F., Bonizzi G., Kirschvink N., Delhalle S., Desmecht D., Merville M.P., Bours V., Lekeux P. Correlation between nuclear factor-kappaB activity in bronchial brushing samples and lung dysfunction in an animal model of asthma. Am. J. Resp. Crit. Care Med. 2000, 161:1314-1321.
16. Busse W.W., Lemanske R.F. Expert Panel Report 3: moving forward to improve asthma care. J. Allergy Clin. Immunol. 2007, 120:1012-1014.
17. Caswell J.L., Middleton D.M., Gordon J.R. Production and functional characterization of recombinant bovine interleukin-8 as a specific neutrophil activator and chemoattractant. Vet. Immunol. Immunopathol. 1999, 67:327-340.
18. Caswell J.L., Middleton D.M., Gordon J.R. The importance of interleukin-8 as a neutrophil chemoattractant in the lungs of cattle with pneumonic pasteurellosis. Can. J. Vet. Res. 2001, 65:229-232.
19. Chopra P., Kanoje V., Semwal A., Ray A. Therapeutic potential of inhaled p38 mitogen-activated protein kinase inhibitors for inflammatory pulmonary diseases. Expert Opin. Investig. Drugs 2008, 17:1411-1425.
20. Clienti S., Morjaria J.B., Basile E., Polosa R. Monoclonal antibodies for the treatment of severe asthma. Curr. Allergy Asthma Rep. 2011, 11:253-260.
21. Cook V.L., Neuder L.E., Blikslager A.T., Jones S.L. The effect of lidocaine on in vitro adhesion and migration of equine neutrophils. Vet. Immunol. Immunopathol. 2009, 129:137-142.
22. Cordeau M.E., Joubert P., Dewachi O., Hamid Q., Lavoie J.P. IL-4, IL-5 and IFN-gamma mRNA expression in pulmonary lymphocytes in equine heaves. Vet. Immunol. Immunopathol. 2004, 97:87-96.
23. Costabel U., Bonella F., Guzman J. Chronic hypersensitivity pneumonitis. Clin. Chest Med. 2012, 33:151-163.
24. Cote O., Clark M.E., Viel L., Labbe G., Seah S.Y., Khan M.A., Douda D.N., Palaniyar N., Bienzle D. Secretoglobin 1A1 and 1A1A differentially regulate neutrophil reactive oxygen species production, phagocytosis and extracellular trap formation. PloS One 2014, 9:e96217.
25. Couetil L.L., Art T., de Moffarts B., Becker M., Melotte D., Jaspar F., Bureau F., Lekeux P. Effect of beclomethasone dipropionate and dexamethasone isonicotinate on lung function, bronchoalveolar lavage fluid cytology, and transcription factor expression in airways of horses with recurrent airway obstruction. J. Vet. Intern. Med. 2006, 20:399-406.
26. Couetil L.L., Hoffman A.M., Hodgson J., Buechner-Maxwell V., Viel L., Wood J.L., Lavoie J.P. Inflammatory airway disease of horses. J. Vet. Intern. Med. 2007, 21:356-361.
27. Couetil L.L., Rosenthal F.S., Simpson C.M. Forced expiration: a test for airflow obstruction in horses. J. Appl. Physiol. 2000, 88:1870-1879.
28. Debrue M., Hamilton E., Joubert P., Lajoie-Kadoch S., Lavoie J.P. Chronic exacerbation of equine heaves is associated with an increased expression of interleukin-17 mRNA in bronchoalveolar lavage cells. Vet. Immunol. Immunopathol. 2005, 105:25-31.
29. Dewachi O., Joubert P., Hamid Q., Lavoie J.P. Expression of interleukin (IL)-5 and IL-9 receptors on neutrophils of horses with heaves. Vet. Immunol. Immunopathol. 2006, 109:31-36.
30. DiSanto M.E., Stein R., Chang S., Hypolite J.A., Zheng Y., Zderic S., Wein A.J., Chacko S. Alteration in expression of myosin isoforms in detrusor smooth muscle following bladder outlet obstruction. Am. J. Physiol. Cell Physiol. 2003, 285:C1397-C1410.
31. Dixon P.M., McGorum B. Pasture-associated seasonal respiratory disease in two horses. Vet. Rec. 1990, 126:9-12.
32. Douglass J., Dhami D., Bulpitt M., Lindley I.J., Shute J., Church M.K., Holgate S.T. Intradermal challenge with interleukin-8 causes tissue oedema and neutrophil accumulation in atopic and non-atopic human subjects. Clin. Exp. Allergy 1996, 26:1371-1379.
33. Erle D.J., Sheppard D. The cell biology of asthma. J. Cell. Biol. 2014, 205:621-631.
34. Fahy J.V., Kim K.W., Liu J., Boushey H.A. Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. J. Allergy Clin. Immunol. 1995, 95:843-852.
35. Fairbairn S.M., Page C.P., Lees P., Cunningham F.M. Early neutrophil but not eosinophil or platelet recruitment to the lungs of allergic horses following antigen exposure. Clin. Exp. Allergy 1993, 23:821-828.
36. Fermaglich D.H., Horohov D.W. The effect of aging on immune responses. Vet. Clin. North Am. Equine Pract. 2002, 18:621-630. ix.
37. Franceschi C., Bonafe M., Valensin S., Olivieri F., De Luca M., Ottaviani E., De Benedictis G. Inflamm-aging: an evolutionary perspective on immunosenescence. Ann. NY Acad. Sci. 2000, 908:244-254.
38. Franchini M., Gill U., von Fellenberg R., Bracher V.D. Interleukin-8 concentration and neutrophil chemotactic activity in bronchoalveolar lavage fluid of horses with chronic obstructive pulmonary disease following exposure to hay. Am. J. Vet. Res. 2000, 61:1369-1374.
39. Franchini M., Gilli U., Akens M.K., Fellenberg R.V., Bracher V. The role of neutrophil chemotactic cytokines in the pathogenesis of equine chronic obstructive pulmonary disease (COPD). Vet. Immunol. Immunopathol. 1998, 66:53-65.
40. Fu J.J., Baines K.J., Wood L.G., Gibson P.G. Systemic inflammation is associated with differential gene expression and airway neutrophilia in asthma. OMICS 2013, 17:187-199.
41. Giembycz M.A., Newton R. Harnessing the clinical efficacy of phosphodiesterase 4 inhibitors in inflammatory lung diseases: dual-selective phosphodiesterase inhibitors and novel combination therapies. Handb. Exp. Pharmacol. 2011, 415-446.
42. Giguere S., Viel L., Lee E., MacKay R.J., Hernandez J., Franchini M. Cytokine induction in pulmonary airways of horses with heaves and effect of therapy with inhaled fluticasone propionate. Vet. Immunol. Immunopathol. 2002, 85:147-158.
43. Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA), 2014. Available from: . http://www.ginasthma.org/.
44. Hanania N.A., King M.J., Braman S.S., Saltoun C., Wise R.A., Enright P., Falsey A.R., Mathur S.K., Ramsdell J.W., Rogers L., Stempel D.A., Lima J.J., Fish J.E., Wilson S.R., Boyd C., Patel K.V., Irvin C.G., Yawn B.P., Halm E.A., Wasserman S.I., Sands M.F., Ershler W.B., Ledford D.K. Asthma in the elderly: current understanding and future research needs - a report of a National Institute on Aging (NIA) workshop. J. Allergy Clin. Immunol. 2011, 128:S4-S24.
45. Hansen S., Baptiste K.E., Fjeldborg J., Betancourt A., Horohov D.W. A comparison of pro-inflammatory cytokine mRNA expression in equine bronchoalveolar lavage (BAL) and peripheral blood. Vet. Immunol. Immunopathol. 2014, 158:238-243.
46. Hansen S., Sun L., Baptiste K.E., Fjeldborg J., Horohov D.W. Age-related changes in intracellular expression of IFN-gamma and TNF-alpha in equine lymphocytes measured in bronchoalveolar lavage and peripheral blood. Dev. Comp. Immunol. 2013, 39:228-233.
47. Hein W.R., Griebel P.J. A road less travelled: large animal models in immunological research. Nat. Rev. Immunol. 2003, 3:79-84.
48. Hirota J.A., Nguyen T.T., Schaafsma D., Sharma P., Tran T. Airway smooth muscle in asthma: phenotype plasticity and function. Pulm. Pharmacol. Ther. 2009, 22:370-378.
49. Hol J., Wilhelmsen L., Haraldsen G. The murine IL-8 homologues KC, MIP-2, and LIX are found in endothelial cytoplasmic granules but not in Weibel-Palade bodies. J. Leukoc. Biol. 2010, 87:501-508.
50. Hopkin J. Immune and genetic aspects of asthma, allergy and parasitic worm infections: evolutionary links. Parasite Immunol. 2009, 31:267-273.
51. Horohov D.W., Adams A.A., Chambers T.M. Immunosenescence of the equine immune system. J. Comp. Pathol. 2010, 142(Suppl. 1):S78-S84.
52. Horohov D.W., Kydd J.H., Hannant D. The effect of aging on T cell responses in the horse. Dev. Comp. Immunol. 2002, 26:121-128.
53. Hotchkiss J.W., Reid S.W., Christley R.M. A survey of horse owners in Great Britain regarding horses in their care. Part 2: Risk factors for recurrent airway obstruction. Equine Vet. J. 2007, 39:301-308.
54. Jean D., Vrins A., Beauchamp G., Lavoie J.P. Evaluation of variations in bronchoalveolar lavage fluid in horses with recurrent airway obstruction. Am. J. Vet. Res. 2011, 72:838-842.
55. Jeffery P., Holgate S., Wenzel S. Methods for the assessment of endobronchial biopsies in clinical research: application to studies of pathogenesis and the effects of treatment. Am. J. Respir. Crit. Care Med. 2003, 168:S1-S17.
56. Jost U., Klukowska-Rotzler J., Dolf G., Swinburne J.E., Ramseyer A., Bugno M., Burger D., Blott S., Gerber V. A region on equine chromosome 13 is linked to recurrent airway obstruction in horses. Equine Vet. J. 2007, 39:236-241.
57. Joubert P., Cordeau M.E., Lavoie J.P. Cytokine mRNA expression of pulmonary macrophages varies with challenge but not with disease state in horses with heaves or in controls. Vet. Immunol. Immunopathol. 2011, 142:236-242.
58. Katepalli M.P., Adams A.A., Lear T.L., Horohov D.W. The effect of age and telomere length on immune function in the horse. Dev. Comp. Immunol. 2008, 32:1409-1415.
59. Kaur M., Singh D. Neutrophil chemotaxis caused by chronic obstructive pulmonary disease alveolar macrophages: the role of CXCL8 and the receptors CXCR1/CXCR2. Pharmacol. Exp. Ther. 2013, 347:173-180.
60. Klukowska-Rotzler J., Marti E., Lavoie J.P., Ainsworth D.M., Gerber V., Zurbriggen A., Janda J. Expression of thymic stromal lymphopoietin in equine recurrent airway obstruction. Vet. Immunol. Immunopathol. 2012, 146:46-52.
61. Klukowska-Rotzler J., Swinburne J.E., Drogemuller C., Dolf G., Janda J., Leeb T., Gerber V. The interleukin 4 receptor gene and its role in recurrent airway obstruction in Swiss Warmblood horses. Anim. Genet. 2012, 43:450-453.
62. Kolm G., Zappe H., Schmid R., Riedelberger K., Van den Hoven R. Efficacy of montelukast in the treatment of chronic obstructive pulmonary disease in five horses. Vet. Rec. 2003, 152:804-806.
63. Lambert R.K., Wiggs B.R., Kuwano K., Hogg J.C., Pare P.D. Functional significance of increased airway smooth muscle in asthma and COPD. J. Appl. Physiol. 1993, 74:2771-2781.
64. Lanctot Setlakwe E.L., Lemos K.R., Lavoie-Lamoureux A., Duguay J.D., Lavoie J.P. Airway collagen and elastic fiber content correlates with lung function in equine heaves. Am. J. Physiol. Lung Cell. Mol. Physiol. 2014, 10.1152/ajplung.00019.2014.
65. Lanz S., Gerber V., Marti E., Rettmer H., Klukowska-Rotzler J., Gottstein B., Matthews J.B., Pirie S., Hamza E. Effect of hay dust extract and cyathostomin antigen stimulation on cytokine expression by PBMC in horses with recurrent airway obstruction. Vet. Immunol. Immunopathol. 2013, 155:229-237.
66. Lavoie-Lamoureux A., Beauchamp G., Quessy S., Martin J.G., Lavoie J.P. Systemic inflammation and priming of peripheral blood leukocytes persist during clinical remission in horses with heaves. Vet. Immunol. Immunopathol. 2012, 146:35-45.
67. Lavoie-Lamoureux A., Leclere M., Lemos K., Wagner B., Lavoie J.P. Markers of systemic inflammation in horses with heaves. J. Vet. Intern. Med. 2012, 26:1419-1426.
68. Lavoie-Lamoureux A., Moran K., Beauchamp G., Mauel S., Steinbach F., Lefebvre-Lavoie J., Martin J.G., Lavoie J.P. IL-4 activates equine neutrophils and induces a mixed inflammatory cytokine expression profile with enhanced neutrophil chemotactic mediator release ex vivo. Am. J. Physiol. Lung Cell Mol. Physiol. 2010, 299:L472-L482.
69. Lavoie J.P., Leguillette R., Pasloske K., Charette L., Sawyer N., Guay D., Murphy T., Hickey G.J. Comparison of effects of dexamethasone and the leukotriene D4 receptor antagonist L-708,738 on lung function and airway cytologic findings in horses with recurrent airway obstruction. Am. J. Vet. Res. 2002, 63:579-585.
70. Lavoie J.P., Maghni K., Desnoyers M., Taha R., Martin J.G., Hamid Q.A. Neutrophilic airway inflammation in horses with heaves is characterized by a Th2-type cytokine profile. Am. J. Respir. Crit. Care Med. 2001, 164:1410-1413.
71. Lavoie J.P., Pasloske K., Joubert P., Cordeau M.E., Mancini J., Girard Y., Friesen R.W., Frenette R., Blouin M., Young R.N., Hickey G. Lack of clinical efficacy of a phosphodiesterase-4 inhibitor for treatment of heaves in horses. J. Vet. Intern. Med. 2006, 20:175-181.
72. Lavoie J.P., Thompson D., Hamilton E., Debrue M., David F., Hickey G. Effects of a MAPK p38 inhibitor on lung function and airway inflammation in equine recurrent airway obstruction. Equine Vet. J. 2008, 40:577-583.
73. Le Bellego F., Perera H., Plante S., Chakir J., Hamid Q., Ludwig M.S. Mechanical strain increases cytokine and chemokine production in bronchial fibroblasts from asthmatic patients. Allergy 2009, 64:32-39.
74. Leclere M., Lavoie-Lamoureux A., Gelinas-Lymburner E., David F., Martin J.G., Lavoie J.P. Effect of antigenic exposure on airway smooth muscle remodeling in an equine model of chronic asthma. Am. J. Respir. Cell Mol. Biol. 2011, 45:181-187.
75. Leclere M., Lavoie-Lamoureux A., Joubert P., Relave F., Lanctot Setlakwe E., Beauchamp G., Couture C., Martin J.G., Lavoie J.P. Corticosteroids and antigen avoidance decrease airway smooth muscle mass in an equine asthma model. Am. J. Respir. Cell Mol. Biol. 2012, 47:589-596.
76. Leclere M., Lavoie-Lamoureux A., Joubert P., Relave F., Setlakwe E.L., Beauchamp G., Couture C., Martin J.G., Lavoie J.P. Corticosteroids and antigen avoidance decrease airway smooth muscle mass in an equine asthma model. Am. J. Respir. Cell Mol. Biol. 2012, 47:589-596.
77. Lee N., Shin M.S., Kang I. T-cell biology in aging, with a focus on lung disease. J. Gerontol. A: Biol. Sci. Med. Sci. 2012, 67:254-263.
78. Leguillette R., Laviolette M., Bergeron C., Zitouni N., Kogut P., Solway J., Kachmar L., Hamid Q., Lauzon A.M. Myosin, transgelin, and myosin light chain kinase: expression and function in asthma. Am. J. Respir. Crit. Care Med. 2009, 179:194-204.
79. Linden A., Dahlen B. Interleukin-17 cytokine signalling in patients with asthma. The Eur. Respir. J. 2014, 10.1183/09031936.00002314.
80. Lommatzsch M., Julius P., Kuepper M., Garn H., Bratke K., Irmscher S., Luttmann W., Renz H., Braun A., Virchow J.C. The course of allergen-induced leukocyte infiltration in human and experimental asthma. J. Allergy Clin. Immunol. 2006, 118:91-97.
81. Lopuhaa C.E., Out T.A., Jansen H.M., Aalberse R.C., van der Zee J.S. Allergen-induced bronchial inflammation in house dust mite-allergic patients with or without asthma. Clin. Exp. Allergy 2002, 32:1720-1727.
82. Ludwig M.S., Ftouhi-Paquin N., Huang W., Page N., Chakir J., Hamid Q. Mechanical strain enhances proteoglycan message in fibroblasts from asthmatic subjects. Clin. Exp. Allergy 2004, 34:926-930.
83. Lugo J., Stick J.A., Peroni J., Harkema J.R., Derksen F.J., Robinson N.E. Safety and efficacy of a technique for thoracoscopically guided pulmonary wedge resection in horses. Am. J. Vet. Res. 2002, 63:1232-1240.
84. Mann B.S., Chung K.F. Blood neutrophil activation markers in severe asthma: lack of inhibition by prednisolone therapy. Respir. Res. 2006, 7:59.
85. Marr K.A., Foster A.P., Lees P., Cunningham F.M., Page C.P. Effect of antigen challenge on the activation of peripheral blood neutrophils from horses with chronic obstructive pulmonary disease. Res. Vet. Sci. 1997, 62:253-260.
86. Matera M.G., Page C., Cazzola M. PDE inhibitors currently in early clinical trials for the treatment of asthma. Expert. Opin. Investig. Drugs 2014, 1-9.
87. Mohamed J.S., Lopez M.A., Boriek A.M. Mechanical stretch up-regulates microRNA-26a and induces human airway smooth muscle hypertrophy by suppressing glycogen synthase kinase-3beta. J. Biol. Chem. 2010, 285:29336-29347.
88. Nair P., Gaga M., Zervas E., Alagha K., Hargreave F.E., O'Byrne P.M., Stryszak P., Gann L., Sadeh J., Chanez P. Safety and efficacy of a CXCR2 antagonist in patients with severe asthma and sputum neutrophils: a randomized, placebo-controlled clinical trial. Clin. Exp. Allergy 2012, 42:1097-1103.
89. Nakagome K., Matsushita S., Nagata M. Neutrophilic inflammation in severe asthma. Int. Arch. Allergy Immunol. 2012, 158(Suppl 1):96-102.
90. Neuhaus S., Bruendler P., Frey C.F., Gottstein B., Doherr M.G., Gerber V. Increased parasite resistance and recurrent airway obstruction in horses of a high-prevalence family. J. Vet. Intern. Med. 2010, 24:407-413.
91. Nials A.T., Uddin S. Mouse models of allergic asthma: acute and chronic allergen challenge. Dis. Model. Mech. 2008, 1:213-220.
92. Nocker R.E., Out T.A., Weller F.R., Mul E.P., Jansen H.M., van der Zee J.S. Influx of neutrophils into the airway lumen at 4 h after segmental allergen challenge in asthma. Int. Arch. Allergy Immunol. 1999, 119:45-53.
93. Norzila M.Z., Fakes K., Henry R.L., Simpson J., Gibson P.G. Interleukin-8 secretion and neutrophil recruitment accompanies induced sputum eosinophil activation in children with acute asthma. Am. J. Respir. Crit. Care Med. 2000, 161:769-774.
94. Oliver M.N., Fabry B., Marinkovic A., Mijailovich S.M., Butler J.P., Fredberg J.J. Airway hyperresponsiveness, remodeling, and smooth muscle mass: right answer, wrong reason?. Am. J. Respir. Cell Mol. Biol. 2007, 37:264-272.
95. Ordonez C.L., Shaughnessy T.E., Matthay M.A., Fahy J.V. Increased neutrophil numbers and IL-8 levels in airway secretions in acute severe asthma: clinical and biologic significance. Am. J. Respir. Crit. Care Med. 2000, 161:1185-1190.
96. Park J.A., Drazen J.M., Tschumperlin D.J. The chitinase-like protein YKL-40 is secreted by airway epithelial cells at base line and in response to compressive mechanical stress. J. Biol. Chem. 2010, 285:29817-29825.
97. Park J.A., Tschumperlin D.J. Chronic intermittent mechanical stress increases MUC5AC protein expression. Am. J. Respir. Cell Mol. Biol. 2009, 41:459-466.
98. Pera T., Zuidhof A., Valadas J., Smit M., Schoemaker R.G., Gosens R., Maarsingh H., Zaagsma J., Meurs H. Tiotropium inhibits pulmonary inflammation and remodelling in a guinea pig model of COPD. Eur. Respir. J. 2011, 38:789-796.
99. Pini L., Hamid Q., Shannon J., Lemelin L., Olivenstein R., Ernst P., Lemiere C., Martin J.G., Ludwig M.S. Differences in proteoglycan deposition in the airways of moderate and severe asthmatics. Eur. Respir. J. 2007, 29:71-77.
100. Pirie R.S., Collie D.D., Dixon P.M., McGorum B.C. Inhaled endotoxin and organic dust particulates have synergistic proinflammatory effects in equine heaves (organic dust-induced asthma). Clin. Exp. Allergy 2003, 33:676-683.
101. Qiu Y., Zhu J., Bandi V., Guntupalli K.K., Jeffery P.K. Bronchial mucosal inflammation and upregulation of CXC chemoattractants and receptors in severe exacerbations of asthma. Thorax 2007, 62:475-482.
102. Racine J., Gerber V., Feutz M.M., Riley C.P., Adamec J., Swinburne J.E., Couetil L.L. Comparison of genomic and proteomic data in recurrent airway obstruction affected horses using ingenuity pathway analysis. BMC Vet. Res. 2011, 7:48.
103. Ramseyer A., Gaillard C., Burger D., Straub R., Jost U., Boog C., Marti E., Gerber V. Effects of genetic and environmental factors on chronic lower airway disease in horses. J. Vet. Intern. Med. 2007, 21:149-156.
104. Relave F., David F., Leclere M., Alexander K., Bussieres G., Lavoie J.P., Marcoux M. Evaluation of a thoracoscopic technique using ligating loops to obtain large lung biopsies in standing healthy and heaves-affected horses. Vet. Surg. 2008, 37:232-240.
105. Relave F., David F., Leclere M., Alexander K., Helie P., Meulyzer M., Lavoie J.P., Marcoux M. Thoracoscopic lung biopsies in heaves-affected horses using a bipolar tissue sealing system. Vet. Surg. 2010, 39:839-846.
106. Riihimaki M., Raine A., Pourazar J., Sandstrom T., Art T., Lekeux P., Couetil L., Pringle J. Epithelial expression of mRNA and protein for IL-6, IL-10 and TNF-alpha in endobronchial biopsies in horses with recurrent airway obstruction. BMC Vet. Res. 2008, 4:8.
107. Robinson N.E. International Workshop on Equine Chronic Airway Disease. Equine Vet. J. 2001, 33:5-19.
108. Roche W.R., Beasley R., Williams J.H., Holgate S.T. Subepithelial fibrosis in the bronchi of asthmatics. Lancet 1989, 1:520-524.
109. Rohde G., Message S.D., Haas J.J., Kebadze T., Parker H., Laza-Stanca V., Khaitov M.R., Kon O.M., Stanciu L.A., Mallia P., Edwards M.R., Johnston S.L. Cxc-chemokines and antimicrobial peptides in rhinovirus-induced experimental asthma exacerbations. Clin. Exp. Allergy 2014, 44:930-939.
110. Schnabel C.L., Wagner S., Wagner B., Duran M.C., Babasyan S., Nolte I., Pfarrer C., Feige K., Murua Escobar H., Cavalleri J.M. Evaluation of the reactivity of commercially available monoclonal antibodies with equine cytokines. Vet. Immunol. Immunopathol. 2013, 156:1-19.
111. Seahorn T.L., Beadle R.E. Summer pasture-associated obstructive pulmonary disease in horses: 21 cases (1983-1991). J. Am. Vet. Med. Assoc. 1993, 202:779-782.
112. Seok J., Shaw Warren H., Cuenca A.G., Mindrinos M.N., Baker H.V., Wu W., Richards D.R., McDonald-Smith G.P., Gao H., Hennessy L., Finnerty C.C., Lopez C.M., Honari S., Moore E.E., Minei J.P., Cuschieri J., Bankey P.E., Johnson J.L., Sperry J., Nathens A.B., Billiar T.R., West M.A., Jeschke M.G., Klein M.B., Gamelli R.L., Gibran N.S., Brownstein B.H., Miller-Graziano C., Calvano S.E., Mason P.H., Cobb J.P., Rahme L.G., Lowry S.F., Maier R.V., Moldawer L.L., Herndon D.N., Davis R.W., Xiao W., Tompkins R.G. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc. Natl. Acad. Sci. U.S.A 2013, 110:3507-3512. Inflammation and Host Response to Injury L. S. C. R. P.
113. Strachan D.P. Hay fever, hygiene, and household size. BMJ 1989, 299:1259-1260.
114. Tremblay G.M., Ferland C., Lapointe J.M., Vrins A., Lavoie J.P., Cormier Y. Effect of stabling on bronchoalveolar cells obtained from normal and COPD horses. Equine Vet. J. 1993, 25:194-197.
115. Turner S., Paton J., Higgins B., Douglas G., British Guidelines on the Management of Asthma British guidelines on the management of asthma: what's new for 2011?. Thorax 2011, 66:1104-1105.
116. Van Erck E., Votion D., Art T., Lekeux P. Qualitative and quantitative evaluation of equine respiratory mechanics by impulse oscillometry. Equine Vet. J. 2006, 38:52-58.
117. Wade C.M., Giulotto E., Sigurdsson S., Zoli M., Gnerre S., Imsland F., Lear T.L., Adelson D.L., Bailey E., Bellone R.R., Blocker H., Distl O., Edgar R.C., Garber M., Leeb T., Mauceli E., MacLeod J.N., Penedo M.C., Raison J.M., Sharpe T., Vogel J., Andersson L., Antczak D.F., Biagi T., Binns M.M., Chowdhary B.P., Coleman S.J., Della Valle G., Fryc S., Guerin G., Hasegawa T., Hill E.W., Jurka J., Kiialainen A., Lindgren G., Liu J., Magnani E., Mickelson J.R., Murray J., Nergadze S.G., Onofrio R., Pedroni S., Piras M.F., Raudsepp T., Rocchi M., Roed K.H., Ryder O.A., Searle S., Skow L., Swinburne J.E., Syvanen A.C., Tozaki T., Valberg S.J., Vaudin M., White J.R., Zody M.C., Lander E.S., Lindblad-Toh K., Broad Institute Genome Sequencing Platform, Broad Institute Whole Genome Assembly Team Genome sequence, comparative analysis, and population genetics of the domestic horse. Science 2009, 326:865-867.
118. Walter M.J., Holtzman M.J. A centennial history of research on asthma pathogenesis. Am. J. Respir. Cell Mol. Biol. 2005, 32:483-489.
119. Wenzel S.E. Asthma phenotypes: the evolution from clinical to molecular approaches. Nat. Med. 2012, 18:716-725.
120. Wilson J.W., Li X. The measurement of reticular basement membrane and submucosal collagen in the asthmatic airway. Clin. Exp. Allergy 1997, 27:363-371.
121. Wood L.G., Baines K.J., Fu J., Scott H.A., Gibson P.G. The neutrophilic inflammatory phenotype is associated with systemic inflammation in asthma. Chest 2012, 142:86-93.
122. Yang Y.G., Tian W.M., Zhang H., Li M., Shang Y.X. Nerve growth factor exacerbates allergic lung inflammation and airway remodeling in a rat model of chronic asthma. Exp. Ther. Med. 2013, 6:1251-1258.